Artificial Intelligence (AI) is transforming not only business operations but also the fundamental assumptions of enterprise management. As knowledge, analytical capability, and execution become increasingly democratized through AI, traditional sources of competitive advantage—including scale, information asymmetry, and operational efficiency—are becoming less sustainable. This paper proposes Enterprise Redefinition, a management framework describing how organizations continuously redesign themselves to create sustainable Future Value in the Age of AI. Unlike conventional transformation approaches that focus on optimizing existing organizations, Enterprise Redefinition conceptualizes transformation as a continuous organizational capability involving the coordinated re-examination and redesign of five interdependent dimensions: Purpose, Business, Organization, Capital, and Leadership. Importantly, these dimensions do not change at the same frequency: enduring elements of organizational purpose may remain stable, while the expression and realization of that purpose evolve in response to technological and societal change. The paper introduces the Enterprise Redefinition Framework, the Enterprise Redefinition Process, and the Enterprise Redefinition Capability Model as integrated approaches to continuous enterprise evolution, together with a maturity model and eleven research propositions intended to establish a foundation for future empirical studies. The central argument is that the primary source of competitive advantage in the Age of AI is no longer superior execution of existing business models but the capability to repeatedly redefine the enterprise itself. A companion working paper, "Future Value Theory" (SSRN: https://ssrn.com/abstract=7120980), provides the theoretical foundation. Keywords: Enterprise Redefinition; Future Value; Artificial Intelligence; Strategic Management; Dynamic Capabilities; Organizational Transformation; Business Model Innovation; Leadership. JEL: M10, M14, O31, O33, G34, D23.
No takes yet. Share an insight, caveat, or question.
Naoki Kadowaki (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: